Rendered visual concept — not inventory photography. Label text in imagery is decorative.
Growth Hormone Axis
Tesamorelin
Currently unavailable
Stabilized GHRH (1-44) analogue
Strength
5 mg
Vial count
Unspecified
Strength of evidence
Approved medicine (specific indications)
Research summary
GHRH analogue studied for visceral adipose tissue in a specific clinical population.
Regulatory status
Approved only as a specific branded prescription product for a narrow indication.
No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.
Information only. Purchases and payments are disabled.
Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.